Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.
about
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins.Influenza virus neuraminidase (NA): a target for antivirals and vaccines.Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in MiceRecombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza VirusUniversal influenza vaccines: Shifting to better vaccines.Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.Progress in developing virus-like particle influenza vaccines.Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategiesAnalysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in KoreaNeuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.Inactivated influenza virus vaccines: the future of TIV and QIV.Identification of Residues That Affect Oligomerization and/or Enzymatic Activity of Influenza Virus H5N1 Neuraminidase Proteins.From Variation of Influenza Viral Proteins to Vaccine Development.Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection.Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge ModelVaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.Comparison of the Efficacy of N9 Neuraminidase-specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies.A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice.Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans.H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines.Antibodies directed towards neuraminidase N1 control disease in a mouse model of influenza.Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.Universal influenza vaccines, science fiction or soon reality?Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus.Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.Avian Influenza A Virus Pandemic Preparedness and Vaccine DevelopmentNeuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase SubtypeNeuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectivenessSubstrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic ActivityAntiviral Activity of Fermented Ginseng Extracts against a Broad Range of Influenza Viruses
P2860
Q30151352-8060F41B-EDA1-4F78-BC37-296E12830DD5Q30249879-A378BA0D-6244-4331-9F06-C376E4BD7B90Q30374446-E48878B6-9C3C-4164-819B-E24CDDA666E8Q30380287-382B3E17-79D2-416C-9BFA-CE7C172769B9Q30380785-4BB3BC42-425A-4059-A97E-EAAD7E7C4969Q30380945-67E072D6-5FE4-4FD5-92BB-5375CDDBDBBCQ30386388-0E8EA4E3-E581-4EBD-A174-91753B124703Q30386612-E8C365DD-7F17-4CF9-A5D8-755846EC71F6Q30386640-EF9FE9D1-D0D6-4C27-8565-84121671DAB8Q30386823-9554B4C2-2FDD-4776-8B6F-B92BE610D438Q30400179-B29D8DD9-B746-4B05-9B65-BAA8DEF7A8A6Q36296560-6BC0AAE0-59C0-4016-9621-5FD5EE11ADB2Q36408162-973E481F-7206-4F97-97F2-FA685F711D7EQ37369509-72F3E189-B2AC-45E5-946F-1C2441634B92Q38683726-1F3F3622-505B-486D-B57F-52C3D1D41755Q38752513-7BB09451-5B5D-4E07-8C16-4A46CE7A0D41Q39441534-1111EEFB-D8E9-49B6-B5FC-DC07F7BEF177Q40050261-22137EB8-4B47-4BC4-A7B6-AE95822D918EQ40075978-338716F4-A159-46AD-9128-474455D71992Q41676246-B5FD7169-6200-410C-8652-C226BE601C82Q41933365-40D0D39F-9151-4D9C-AA04-B8951F33675EQ45324380-CED7E0F8-08FE-4538-B36B-D4FDB082320EQ47108278-3418C9CA-6911-40DF-82B3-FE2D3AA130B3Q47132783-28BD4025-6B78-4B57-8704-8EF3C98803B4Q47137425-9C35488F-9AB9-44C5-8141-163BDFB02FF9Q47149344-0221017C-A6F7-4220-9084-4E0C1867A130Q47426452-B4007799-5609-47F1-B053-EACD7EFEB0EBQ50308620-62DEE7A8-7B60-4C06-92AC-D58A958C1DCDQ51003270-A96BC2C3-A617-465E-9EDC-120B1E78380AQ52602393-8600785B-0D74-4E5D-AEBC-9E7FB3C2D0D4Q52609074-4C25F2AF-6505-4DA3-B9C7-F847988430A1Q52721336-890AF7EC-1AEB-465E-8D1B-13D3A5118EAEQ55306089-D1A9A1F5-6729-4832-8A3A-146F9DCDEAD5Q56561344-8E61E6E4-6052-425B-802A-813D4B24861DQ57093905-1D686830-072B-4809-A26D-CE20E3A6B6A9Q57094018-015A8801-6AAE-4590-849A-D6F64F7A120AQ57469896-7BC2A24F-3427-41C0-BBF9-AF3E5486AFD4Q58773293-80BB7E35-AFF7-4279-A876-032E2296E886
P2860
Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Vaccination with adjuvanted re ...... uenza virus infection in mice.
@ast
Vaccination with adjuvanted re ...... uenza virus infection in mice.
@en
type
label
Vaccination with adjuvanted re ...... uenza virus infection in mice.
@ast
Vaccination with adjuvanted re ...... uenza virus infection in mice.
@en
prefLabel
Vaccination with adjuvanted re ...... uenza virus infection in mice.
@ast
Vaccination with adjuvanted re ...... uenza virus infection in mice.
@en
P2093
P2860
P50
P356
P1433
P1476
Vaccination with adjuvanted re ...... luenza virus infection in mice
@en
P2093
Ariana Hirsh
Rebecca J Cox
Teddy John Wohlbold
P2860
P304
P356
10.1128/MBIO.02556-14
P577
2015-03-10T00:00:00Z